Cardio-Oncology Nursing Education (CONE): an innovative educational program for nurses caring for patients with cancer and concurrent cardiovascular disease
BACKGROUND: Cardio-oncology addresses the cardiovascular health of patients with cancer, an area of growing importance as cancer survival rates improve. Nurses play a central role in monitoring, educating, and coordinating care, yet a structured, standardized, competency-based education is lacking. This article describes the development, structure, and implementation of the Cardio-Oncology Nursing Education (CONE) program, a global educational initiative designed to equip nurses with specialized knowledge and skills to manage cardiovascular complications in patients with cancer. METHODS: The CONE curriculum was developed by an international, multidisciplinary committee, informed by a global nursing learning-needs assessment. It comprises 27 virtual modules, providing 18.25 nursing contact hours, including 10.25 pharmacotherapeutics credits accredited by the American Nurses Credentialing Center, aligned with contemporary evidence-based guidelines. Modules cover cardiovascular risk assessment, therapy-related toxicity, survivorship, and multidisciplinary care coordination. CONCLUSIONS: The CONE program provides a standardized, evidence-based framework for cardio-oncology nursing education, promoting nurse-led, patient-centered care and improving outcomes for cancer survivors. The asynchronous, flexible curriculum addresses global accessibility barriers and supports learner-directed professional development. Future directions include hybrid learning, simulation-based education, and competency-based certification to formalize nursing roles globally.
Authors
- Priya Reehal
- Lisa Nodzon
- Asma Mouhammad Younus
- Edith Pituskin
- Mary Stuart
- Geraldine Lee
- Chelsea Patricia Kriesberg
- Anecita Fadol
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of Alberta (CA)
- University College Cork (IE)
- Izaak Walton Killam Health Centre (CA)
- Moffitt Cancer Center (US)
- Royal Brompton Hospital (GB)
- National Center for Cancer Care and Research (QA)
- Advocate Children's Hospital (US)
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1186/s40959-026-00516-9
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00